APA

Joerger M., von Pawel J., Kraff S., Fischer J. R., Eberhardt W., Gauler T. C., Mueller L., Reinmuth N., Reck M., Kimmich M., Mayer F., Kopp H., Behringer D. M., Ko Y., Hilger R. A., Roessler M., Kloft C., Henrich A., Moritz B., Miller M. C., Salamone S. J. & Jaehde U. (20171222). Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Joerger M, von Pawel J, Kraff S, Fischer J R, Eberhardt W, Gauler T C, Mueller L, Reinmuth N, Reck M, Kimmich M, Mayer F, Kopp H-G, Behringer D M, Ko Y-D, Hilger R A, Roessler M, Kloft C, Henrich A, Moritz B, Miller M C, Salamone S J and Jaehde U. 20171222. Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Joerger M., von Pawel J., Kraff S., Fischer J. R., Eberhardt W., Gauler T. C., Mueller L., Reinmuth N., Reck M., Kimmich M., Mayer F., Kopp H., Behringer D. M., Ko Y., Hilger R. A., Roessler M., Kloft C., Henrich A., Moritz B., Miller M. C., Salamone S. J. and Jaehde U. (20171222). Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Joerger M, von Pawel J, Kraff S, Fischer J R, Eberhardt W, Gauler T C, Mueller L, Reinmuth N, Reck M, Kimmich M, Mayer F, Kopp H-G, Behringer D M, Ko Y-D, Hilger R A, Roessler M, Kloft C, Henrich A, Moritz B, Miller M C, Salamone S J and Jaehde U. Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). : Annals of oncology : official journal of the European Society for Medical Oncology. 20171222.